Guerbet revenues drop due to COVID-19 crisis September 24, 2020 -- Contrast developer Guerbet saw revenues fall 8.4% after currency adjustment in the first half of its financial year due to the impact of the COVID-19 pandemic on the company's sales.
EOS revenues jump as sales resume September 24, 2020 -- Orthopedic imaging technology developer EOS Imaging reported 63% growth in revenues in the first half of the company's financial year as system shipments resumed after being interrupted by the COVID-19 outbreak.
MGH scientists identify PET tracer for Alzheimer's September 23, 2020 -- Massachusetts General Hospital (MGH) scientists have developed a molecular imaging radiotracer that identifies Alzheimer's disease-related gamma-secretase in rodents and macaques that has translational potential for humans.
Sam Hare secures key U.K. job as national adviser September 22, 2020 -- Dr. Sam Hare, the U.K. thoracic radiologist who came to prominence during the pandemic when he called radiographers "the real heroes" and used a plastic cup in a BBC interview to demonstrate how COVID-19 can leave lung damage, was named the new National Specialty Advisor for Imaging for National Health Service England on 21 September.
RapidAI secures large funding boost from Germany September 21, 2020 -- Artificial intelligence (AI) software developer RapidAI has secured $25 million (21 million euros) in funding, which it plans to use to support further development of its AI software for cerebrovascular imaging around the world.
Safety of 3D printing comes under growing scrutiny September 21, 2020 -- The Office for Product Safety and Standards in the U.K. has announced plans to focus on the safety of 3D printing technologies, according to an article published by law firm Pinsent Masons.
iCAD promotes Karolinska decision-support study September 21, 2020 -- Computer-aided detection (CAD) software developer iCAD is highlighting research published on 8 September in Radiology that attests to the ability of its ProFound AI Risk clinical decision-support software to provide accurate two-year breast cancer risk estimates.